Skip to main content
. Author manuscript; available in PMC: 2021 Aug 13.
Published in final edited form as: Pediatr Infect Dis J. 2020 Jun;39(6):483–488. doi: 10.1097/INF.0000000000002602

Table 3.

Comparison of Cohort 2 sign and symptom characteristics at time of illness presentation for children with GAS1 colonization with a new GAS emm-type and those with a previous GAS emm-type.

Symptom Characteristics New GAS emm-type Carrier2
N=113
Previous GAS emm-type Carrier
N=103
OR4 (95% CI5)

Sore Throat6    Mild
    Moderate/Severe
0 (0)
11 (100)
5 (50)
5 (50)
ref
No estimate
Abnormal Pharyngeal Exam7 8 (73) 8 (80) 1.5 (0.2–11.5)
Fever6 2 (18) 1 (10) 0.5 (0.0–6.5)
Headache6 3 (27) 0 (0) No estimate
Abdominal Pain6 2 (18) 1 (10) 0.5 (0.0–6.5)
Vomiting6 2 (18) 0 (0) No estimate
Activity6    Normal
      Decreased
7 (64)
4 (36)
9 (90)
1 (10)
ref
0.2 (0.0–2.2)
Cough6,8 3 (27) 7 (78) 9.3 (1.2–73.0)
Nasal Congestion6 4 (36) 8 (80) 7.0 (1.0–50.6)
One URI9 Symptom10 5 (45) 9 (90) 10.8 (1.0–117.0)
Two URI Symptoms10 2 (18) 6 (67) 9 (1.1–71.0)
1

GAS: group A Streptococcus

2

Columns N (%) except where otherwise specified.

3

One child with new GAS emm-type carriage and two children with established GAS emm-type carriage had missing symptom data and were excluded from this comparison.

4

OR: odds ratio; estimated using Fisher’s exact test

5

CI: confidence interval

6

Patient/parent reported

7

Presence of erythema, enanthem, edema, petechiae or exudates present on the uvula, palate, tonsils or tongue as noted by trained research staff.

8

Missing cough data on one child

9

URI: upper respiratory infection

10

Symptoms include cough or nasal congestion